Morton Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
LMFP
ATO
HCM
AAMU
FWCM
Morton Capital Management's ABBV Position: Q2 2026 in Review
Morton Capital Management increased its AbbVie (ABBV) stake by 4.2% in Q2 2026, buying an estimated $85.8K and bringing the position to 9,961 shares worth $2.51M. The position accounts for 0.34% of the portfolio, ranked #27.
Morton Capital Management first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. 1,329 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Morton Capital Management held 9,961 shares of AbbVie worth $2.51M as of Q2 2026.
- Morton Capital Management bought 399 AbbVie shares in Q2 2026, an estimated $85.8K.
- AbbVie made up 0.34% of Morton Capital Management's portfolio in Q2 2026, its #27 holding.
- Morton Capital Management first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
- 1,329 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Morton Capital Management's 13F filing for Q2 2026, filed 23 Jul 2026.